Filed: 5/15/2026ACC: 0001104659-26-061754
📋 What this filing means
AVORO CAPITAL ADVISORS LLC filed this quarterly 13F‑HR report disclosing 30 equity positions with a total reported market value of $10.16B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
30
Positions
$10.16B
Total AUM (reported)
154.01M
Total Shares
Allocation by class
COMMON$7.48B73.6%
SPONSORED ADR$1.89B18.6%
SPONSORED ADS$770.00M7.6%
ORDINARY SHARES$25.31M0.2%
Portfolio Concentration
Top 3$3.68B36.2%
4–10$4.10B40.4%
11–25$2.31B22.7%
Rest$72.34M0.7%
Top 3 weight
36.2%
Top 10 weight
76.6%
Voting Authority Distribution
Total shares with voting rights: 154.01M
Sole
Full voting authority
154.01M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole30
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings30
Rows:
UNITED THERAPEUTICS CORP
SOLEShares3.01M
TypeSH
Market value$1.57B
15.44%
Sole
3.01M
Shared
0.00
None
0.00
ASCENDIS PHARMA
SOLEShares5.06M
TypeSH
Market value$1.16B
11.39%
Sole
5.06M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares1.82M
TypeSH
Market value$951.76M
9.36%
Sole
1.82M
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares2.89M
TypeSH
Market value$746.26M
7.34%
Sole
2.89M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares1M
TypeSH
Market value$730.25M
7.18%
Sole
1M
Shared
0.00
None
0.00
ARROWHEAD PHARMACEUTICALS INC
SOLEShares10.70M
TypeSH
Market value$670.89M
6.60%
Sole
10.70M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares7.47M
TypeSH
Market value$622.57M
6.12%
Sole
7.47M
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares12.22M
TypeSH
Market value$491.70M
4.84%
Sole
12.22M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares11.43M
TypeSH
Market value$454.02M
4.47%
Sole
11.43M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares3.58M
TypeSH
Market value$388.27M
3.82%
Sole
3.58M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares5.78M
TypeSH
Market value$335.98M
3.31%
Sole
5.78M
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares6.56M
TypeSH
Market value$315.98M
3.11%
Sole
6.56M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares5.70M
TypeSH
Market value$300.24M
2.95%
Sole
5.70M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares5.89M
TypeSH
Market value$236.91M
2.33%
Sole
5.89M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares2.34M
TypeSH
Market value$228.00M
2.24%
Sole
2.34M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares3.33M
TypeSH
Market value$219.70M
2.16%
Sole
3.33M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares12.31M
TypeSH
Market value$104.31M
1.03%
Sole
12.31M
Shared
0.00
None
0.00
DAMORA THERAPEUTICS INC
SOLEShares3.78M
TypeSH
Market value$97.98M
0.96%
Sole
3.78M
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares5.96M
TypeSH
Market value$97.44M
0.96%
Sole
5.96M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares21.70M
TypeSH
Market value$97.00M
0.95%
Sole
21.70M
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares5M
TypeSH
Market value$94.50M
0.93%
Sole
5M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares2.30M
TypeSH
Market value$77.00M
0.76%
Sole
2.30M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares1.20M
TypeSH
Market value$42.43M
0.42%
Sole
1.20M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares1.34M
TypeSH
Market value$32.14M
0.32%
Sole
1.34M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$29.34M
0.29%
Sole
1.50M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
UNITED THERAPEUTICS CORPSOLE | Common | 3.01M | SH | $1.57B 15.44% | 3.01M | 0.00 | 0.00 |
ASCENDIS PHARMASOLE | Sponsored ADR | 5.06M | SH | $1.16B 11.39% | 5.06M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | Common | 1.82M | SH | $951.76M 9.36% | 1.82M | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | Common | 2.89M | SH | $746.26M 7.34% | 2.89M | 0.00 | 0.00 |
ARGENX SESOLE | Sponsored ADR | 1M | SH | $730.25M 7.18% | 1M | 0.00 | 0.00 |
ARROWHEAD PHARMACEUTICALS INCSOLE | Common | 10.70M | SH | $670.89M 6.60% | 10.70M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | Common | 7.47M | SH | $622.57M 6.12% | 7.47M | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | Common | 12.22M | SH | $491.70M 4.84% | 12.22M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 11.43M | SH | $454.02M 4.47% | 11.43M | 0.00 | 0.00 |
CELCUITY INCSOLE | Common | 3.58M | SH | $388.27M 3.82% | 3.58M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | Common | 5.78M | SH | $335.98M 3.31% | 5.78M | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 6.56M | SH | $315.98M 3.11% | 6.56M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | Common | 5.70M | SH | $300.24M 2.95% | 5.70M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | Common | 5.89M | SH | $236.91M 2.33% | 5.89M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | Common | 2.34M | SH | $228.00M 2.24% | 2.34M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | Common | 3.33M | SH | $219.70M 2.16% | 3.33M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | Common | 12.31M | SH | $104.31M 1.03% | 12.31M | 0.00 | 0.00 |
DAMORA THERAPEUTICS INCSOLE | Common | 3.78M | SH | $97.98M 0.96% | 3.78M | 0.00 | 0.00 |
UNIQURE NVSOLE | Common | 5.96M | SH | $97.44M 0.96% | 5.96M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | Common | 21.70M | SH | $97.00M 0.95% | 21.70M | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | Common | 5M | SH | $94.50M 0.93% | 5M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | Common | 2.30M | SH | $77.00M 0.76% | 2.30M | 0.00 | 0.00 |
ALKERMES PLCSOLE | Common | 1.20M | SH | $42.43M 0.42% | 1.20M | 0.00 | 0.00 |
SEPTERNA INCSOLE | Common | 1.34M | SH | $32.14M 0.32% | 1.34M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | Common | 1.50M | SH | $29.34M 0.29% | 1.50M | 0.00 | 0.00 |
Page 1 of 2